Organization Profile

Related Organization(s)

You just read:

European Medicines Agency Accepts Samsung Bioepis' Enbrel(R) Biosimilar Candidate, SB4, for Regulatory Review

News provided by

Samsung Bioepis

Jan 21, 2015, 09:00 ET